Status:
COMPLETED
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
Lead Sponsor:
Aarhus University Hospital Skejby
Collaborating Sponsors:
University of Aarhus
Aarhus University Hospital
Conditions:
Heart Failure, Congestive
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether 48 hours of glucagon-like-peptide-1 (GLP-1) infusion can improve heart function and alter substrate metabolism in non-diabetic patients with heart fai...
Detailed Description
Heart failure is a major complication in patients with ischemic heart disease. It has been shown that many of these patients have areas of viable myocardium that are not effectively contributing to he...
Eligibility Criteria
Inclusion
- Chronic congestive heart failure
- Ischemic heart disease
Exclusion
- Diabetes
- Exercise limiting disease other than heart failure
- Congenital heart disease
- Arterio-venous shunts
- Renal failure
- Valvular heart disease
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00264199
Start Date
December 1 2005
End Date
December 1 2007
Last Update
December 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Afdeling B, Skejby Hospital
Aarhus, Denmark, 8200